Modular soluble nanoarray technology platform

Current molecular diagnostics are limited by complex workflows, high sample input requirements, and slow turnaround times. We have engineered a fundamentally different approach. The Cambridge Nucleomics platform is a proprietary, enzyme-free technology designed to quantify RNA and DNA nucleic acids in one simple, rapid measurement.

Modular soluble nanoarray for single-molecule RNA counting

Nucleomics nanotechnology for RNA counting on nanopores — Cambridge Nucleomics' nanotechnology barcoding for single-molecule target RNA counting. Barcodes are hybridised to the targets so that bulky loops stand out. The barcode structure is translated into an electric signal with characteristic peaks by the nanopore.

Platform Advantages

Unprecedented speed: from sample to actionable insight in one hour
Low input: requires attomoles of target, enabling true point-of-need profiling
High multiplexing: up to 200 distinct RNA/DNA biomarkers simultaneously from an individual sample in a single assay
Simplified workflow: removing complex enzymatic steps drastically reduces sequence errors, contamination and cost

Find out more about our indications.